tiprankstipranks
Holista Colltech Limited (AU:HCT)
ASX:HCT
Australian Market

Holista Colltech Limited (HCT) Share Price & Analysis

1 Followers

HCT Stock Chart & Stats

Day’s RangeAU$0 - AU$0
52-Week Range<AU$0.01 - AU$0.02
Previous CloseAU$0.01
Volume108.10K
Average Volume (3M)N/A
Market Cap
AU$2.23M
Enterprise ValueAU$2.06M
Total Cash (Recent Filing)AU$117.53K
Total Debt (Recent Filing)AU$1.22M
Price to Earnings (P/E)
Beta0.07
Aug 30, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding278,800,067
10 Day Avg. Volume1,475,515
30 Day Avg. VolumeN/A
Standard Deviation0.28
R-Squared0.00376
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

65.41%0.00%0.00%34.59%
65.41%
Insiders
0.00% Other Institutional Investors
34.59% Public Companies and
Individual Investors

HCT FAQ

What was Holista Colltech Limited’s price range in the past 12 months?
Holista Colltech Limited lowest share price was <AU$0.01 and its highest was AU$0.02 in the past 12 months.
    What is Holista Colltech Limited’s market cap?
    Currently, no data Available
    When is Holista Colltech Limited’s upcoming earnings report date?
    Holista Colltech Limited’s upcoming earnings report date is Aug 30, 2024 which is in 37 days.
      How were Holista Colltech Limited’s earnings last quarter?
      Holista Colltech Limited released its earnings results on Feb 28, 2024. The company reported -AU$0.013 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.013.
        Is Holista Colltech Limited overvalued?
        According to Wall Street analysts Holista Colltech Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Holista Colltech Limited pay dividends?
          Holista Colltech Limited does not currently pay dividends.
          What is Holista Colltech Limited’s EPS estimate?
          Holista Colltech Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Holista Colltech Limited have?
          Holista Colltech Limited has 278,800,080 shares outstanding.
            What happened to Holista Colltech Limited’s price movement after its last earnings report?
            Holista Colltech Limited reported an EPS of -AU$0.013 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Holista Colltech Limited?
              Currently, no hedge funds are holding shares in AU:HCT
              ---

              Holista Colltech Limited Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Fundamentals

              Return on Equity
              -1121.25%
              Trailing 12-Months
              Asset Growth
              -38.45%
              Trailing 12-Months

              Company Description

              Holista Colltech Limited

              Holista CollTech Ltd is a research-driven biotech company. Its operating segments include Supplements; Ovine Collagen; Infection Control Solutions; Food Ingredients; and Corporate. Supplements segment is involved in the manufacturing and wholesale distribution of dietary supplements. Ovine collagen segment is involved in the manufacturing and distribution of cosmetic grade collagen. Food ingredients segment is involved in the manufacturing and wholesale distribution of healthy food ingredients. Infection control segment is involved in the infection control solutions. The company generates a majority of its revenue from Supplements segment. Geographically, it generates a majority of its revenue from Malaysia.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Prescient Therapeutics Limited
              Genetic Signatures Ltd.
              Fiji Kava Limited
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis